LPL Financial LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 41.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,379 shares of the company’s stock after selling 4,471 shares during the quarter. LPL Financial LLC’s holdings in Henry Schein were worth $446,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Captrust Financial Advisors purchased a new stake in shares of Henry Schein in the fourth quarter worth approximately $141,000. Advisory Services Network LLC raised its stake in shares of Henry Schein by 430.1% in the fourth quarter. Advisory Services Network LLC now owns 2,099 shares of the company’s stock worth $147,000 after purchasing an additional 1,703 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in shares of Henry Schein by 100.0% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,400 shares of the company’s stock worth $168,000 after purchasing an additional 1,200 shares during the last quarter. Ford Financial Group Inc. purchased a new stake in shares of Henry Schein in the fourth quarter worth approximately $182,000. Finally, Cetera Advisor Networks LLC purchased a new stake in shares of Henry Schein in the fourth quarter worth approximately $210,000. 98.32% of the stock is owned by hedge funds and other institutional investors.
Shares of HSIC opened at $69.75 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.45 and a quick ratio of 0.76. The company has a market cap of $10,958.81, a P/E ratio of 19.38, a price-to-earnings-growth ratio of 1.73 and a beta of 1.05. Henry Schein, Inc. has a 12 month low of $62.56 and a 12 month high of $93.50.
HSIC has been the subject of several analyst reports. Piper Jaffray reissued a “buy” rating and issued a $78.00 price objective on shares of Henry Schein in a research note on Wednesday, December 27th. Barclays initiated coverage on Henry Schein in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $71.00 price objective for the company. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Leerink Swann reissued a “hold” rating on shares of Henry Schein in a research note on Tuesday, February 13th. Finally, BidaskClub raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Saturday, April 14th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company’s stock. Henry Schein has a consensus rating of “Hold” and a consensus target price of $82.31.
TRADEMARK VIOLATION WARNING: This story was posted by Week Herald and is owned by of Week Herald. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://weekherald.com/2018/04/20/lpl-financial-llc-has-446000-stake-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.